EMA Pilots Reduced Parallel Trade Fee To Improve Availability Of Medicines In Malta
This article was originally published in SRA
Executive Summary
The European Medicines Agency has launched a one-year pilot to help increase the availability of centrally authorized medicines in Malta by charging a reduced fee from companies involved in parallel distribution of medicines to the country1,2.
You may also be interested in...
EMA Reduces Parallel Distribution Fees For Malta & Latvia To Improve Medicines Availability
The European Medicines Agency is charging a reduced fee for parallel distribution of centrally authorized medicines to smaller EU member states under a new initiative that aims to improve the availability of medicines. Malta and Latvia have joined in, and two other member states have showed interest in the initiative, which will end in July 2018.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.